Kelyniam Global
corporate_fare Company Profile
Kelyniam Global (OTC:KLYG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for KLYG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-11, rated 9/10.
Recent high-impact activity:
- Kelyniam Global Reports 84% Revenue Surge, Swings to Q1 Operating Profit
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 410 shares in KLYG as of the September 15, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.